http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016155803-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2869 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate | 2016-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e83511084e3936507b281fa5551c9374 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eab3e1976a6d61dae8751468bf1ba264 |
| publicationDate | 2016-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2016155803-A |
| titleOfInvention | Delivery of pharmaceuticals via the human insulin receptor |
| abstract | A humanized mouse antibody that binds to human insulin receptor (HIR) is provided. A humanized mouse antibody that binds to a human insulin receptor (HIR), the antibody comprising: a) a heavy chain of amino acids comprising a constant region and a variable region, wherein the variable region is amino terminal and A complementarity determining region having a carboxyl terminus and inserted between framework regions, wherein the complementarity determining region is a first complementarity determining region located at the amino terminus of the variable region, at the carboxyl terminus of the variable region; A third complementarity determining region located between the first and third complementarity determining regions; and a second complementarity determining region located between the first and third complementarity determining regions. And a humanized antibody comprising a light chain of an amino acid compatible with the heavy chain. [Selection figure] None |
| priorityDate | 2002-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 160.